DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose Read more
DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast cancer Read more
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above Read more